Back to Journals » OncoTargets and Therapy » Volume 8

Original Research

GSK1838705A, an insulin-like growth factor-1 receptor/insulin receptor inhibitor, induces apoptosis and reduces viability of docetaxel-resistant prostate cancer cells both in vitro and in vivo

       
Total article views   HTML views PDF downloads Totals
8,888 Dovepress* 8,371+ 1,578 9,949
PubMed Central* 517 186 703
Totals 8,888 1,764 10,652
*Since 10 April 2015
+Since July 2016

View citations on PubMed and Google Scholar